Qinecsa Sponsors the World Drug Safety Congress Europe
We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress Europe 2024, marking our third year! EUROPE’S MOST EXCITING DRUG SAFETY & PV EVENT The World Drug Safety Congress Europe is where key communities and industries come together to discuss the latest advancements in drug safety. From exploring the use […]
Qinecsa featured in International Pharmaceutical Industry (IPI) editorial
In her latest article for IPI, Qinecsa President, Humaira Qureshi, addresses the practical challenges of integrating medical devices into pharmacovigilance portfolios. She explores the obligations of device manufacturers and offers insights on navigating the complexities of the European Medical Device Regulation (EU MDR). “Understanding medical device regulations is essential for pharmacovigilance professionals seeking to master […]
Qinecsa shares latest innovations with industry media before DIA Global Annual Meeting 2024
Ahead of exhibiting at the 2024 DIA Global Annual Meeting, Qinecsa spoke with industry leading journal Outsourcing Pharma about the company’s latest breakthrough in clinical research technology, how it addresses the current challenges in the industry, and the major trends that will shape the future of pharmaceuticals. Qinecsa discusses the vast volumes of data and […]
Qinecsa releases on-demand webinar on mastering Medical Device regulations
On April 17, 2024, Qinecsa launched its first webinar, offering a deep dive into medical device regulations. The on-demand session, “Mastering Medical Device Regulations (EU) 2017/745,” is designed for pharmacovigilance professionals aiming to excel in compliance and operational effectiveness. The 50-minute webinar offers a thorough analysis of the latest EU medical device regulatory landscape, providing […]
Stanley Capital-backed portfolio company Qinecsa acquires Insife
Press Release Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions. 21st March 2024 — Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announce its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms. This acquisition is in alignment […]
Qinecsa appoints John Freeman JD, M.Sc., B.Sc. to the Board of Directors
Announcement – 14th December 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of John Freeman JD, M.Sc., B.Sc. as Non-executive Director. With a background in Clinical Pharmacology and Law, John has held prominent global leadership roles in pharmacovigilance and risk management. He has worked in the field of pharmacovigilance since […]
Launching the next-generation Literature Management solution
Announcement – Qinecsa Solutions Launches Next-Generation Literature Management Solution in Collaboration with AAICO, Revolutionizing Pharmacovigilance with AI London, December 13, 2023 – Qinecsa Solutions, experts in technology-driven end-to-end pharmacovigilance solutions, proudly announces the launch of its latest literature management solution in partnership with The Applied AI Company (AAICO). This strategic union combines Qinecsa’s medical […]
Qinecsa appoints Arthur Shih as General Counsel
6 November 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of Arthur Shih as General Counsel. With over 25 years in private practice and in-house leadership roles, Arthur brings extensive international legal and commercial experience to support the execution of Qinecsa’s future growth strategy. “Qinecsa is a market-leader […]
Introducing the Qinecsa PV Insights Network: Connecting peers for practical drug safety solutions
Empowering leaders in small pharma and biotech with responsibility for drug safety We are thrilled to announce the launch of the Qinecsa PV Insights Network, an initiative designed specifically for pharmacovigilance (PV) leaders in small pharma and biotech companies who bear the critical responsibility of drug safety. Following the overwhelming response to a series of […]
Stanley Capital-backed portfolio company Qinecsa acquires Commonwealth Informatics
Stanley Capital Partners LLP (SCP) has announced the acquisition of Commonwealth Informatics, Inc. (Commonwealth) by its portfolio company Qinecsa Solutions UK Ltd. (Qinecsa), a leading provider of pharmacovigilance services and technologies to the global pharmaceutical industry. The financial terms of this transaction are not being disclosed. Headquartered in Massachusetts, USA, Commonwealth, an independently-operated subsidiary of […]
